Thermo Fisher to invest $475m into biopharma in 2020
Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.
Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.
The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.